Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT05713734
Eligibility Criteria:
Inclusion Criteria:
* Man with ISTH BAT\>3. If the calculated score includes a surgical bleeding, then two other items of the score should be \>0
* Woman with ISTH BAT \>5 points. If the calculated score includes a surgical or a postpartum bleeding, then two other items of the score should be \>0
Exclusion Criteria:
* Ongoing pregnancy
* Intake of antithrombotic treatment or non-steroidal anti-inflammatory drugs for least 10 days at time of blood collection
* Intake of antifibrinolytic or blood product administration (factor concentrate, frozen fresh plasma, prothrombin complex concentrate) for least 14 days before blood collection
* Active cancer (defined as cancer diagnosis within the last five years or treatment within the two last years before study inclusion)
* Active autoimmune disease
* Active chronic inflammatory disease
* Severe liver disease (cirrhosis \> Child A)
* Renal insufficiency stage 3
* Active or recent infection (within the last 30 days)
* Recent hospitalization (\<3 months)
* Recent surgery (\<3 months)
* Recent trauma requiring medical intervention (\<3 months)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
65 Years
Study:
NCT05713734
Study Brief:
Protocol Section:
NCT05713734